Crossject Société Anonyme (EPA:ALCJ)
France · Delayed Price · Currency is EUR 1.918
-0.004 (-0.21%)
May 14, 2026, 5:35 PM CET
Crossject Société Anonyme Market Cap
Crossject Société Anonyme has a market cap or net worth of €101.15 million as of May 14, 2026. Its market cap has increased by 105.57% in one year.
Market Cap
101.15M
Enterprise Value
118.52M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.92
Market Cap Chart
Since February 20, 2014, Crossject Société Anonyme's market cap has increased from 59.40M to 101.15M, an increase of 70.30%. That is a compound annual growth rate of 4.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 101.37M | -12.24% |
| Dec 31, 2025 | 115.50M | 10.53% |
| Dec 31, 2024 | 104.50M | -44.71% |
| Dec 29, 2023 | 188.99M | 90.83% |
| Dec 30, 2022 | 99.04M | 26.25% |
| Dec 31, 2021 | 78.44M | 0.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 87.28B |
| EssilorLuxottica Société anonyme | 78.49B |
| Sartorius Stedim Biotech | 15.65B |
| Ipsen | 13.56B |
| ABIONYX Pharma | 129.65M |
| Guerbet | 126.15M |
| Innate Pharma | 115.22M |
| OSE Immunotherapeutics | 109.41M |